Compound information
- Natural Products
- ZC2518302
- Molecular Formula
- C23H24N6O2
- Molecular Weight
- 416.196074008 g/mol
- Structure
-
- IUPAC Name
- 3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-N-[4-(pyrimidin-2-ylamino)phenyl]benzamide
- InChI
- InChI=1S/C23H24N6O2/c1-29(2)15-4-8-21(30)26-20-7-3-6-17(16-20)22(31)27-18-9-11-19(12-10-18)28-23-24-13-5-14-25-23/h3-14,16H,15H2,1-2H3,(H,26,30)(H,27,31)(H,24,25,28)/b8-4+
- InChI Key
- OOVMSGVJMRSIKT-XBXARRHUSA-N
- SMILES
- CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3ncccn3)cc2)c1
- Source
- ZINC001875380426
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 99.25 Å2 | LogP | 2.494 |
LogS | -3.996 | LogD | 3.092 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.038 | Pgp substrate | 0.222 |
HIA | 0.964 | F20 % | 0.926 |
F30 % | 0.14 | Caco-2 | -4.992 |
MDCK | -5.763 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.07 | PPB | 50.735 |
VD | 1.432 | Fu | 1.413 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.99 | CYP1A2 substrate | 0.721 |
CYP2A6 substrate | 0.344 | CYP2B6 substrate | 0.629 |
CYP2C19 inhibitor | 0.152 | CYP2C19 substrate | 0.897 |
CYP2C8 substrate | 0.932 | CYP2C9 inhibitor | 0.037 |
CYP2C9 substrate | 0.707 | CYP2D6 inhibitor | 0.149 |
CYP2D6 substrate | 0.969 | CYP2E1 substrate | 0.329 |
CYP3A4 inhibitor | 0.192 | CYP3A4 substrate | 0.967 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.373 | CL | 6.263 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.139 | Hepatotoxicity | 0.74 |
Mutagenicity | 0.035 | Rat Oral Acute Toxicity | 0.076 |
FDAMDD | 0.726 | Skin Sensitization | 0.976 |
Carcinogenicity | 0.018 | Eye Corrosion | 0.004 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.979 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.367 | IGC50 | 3.601 |
LC50FM | 2.232 | LC50DM | 2.526 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.145 | NR-AR-LBD | 0.309 |
NR-AhR | 0.968 | NR-Aromatase | 0.578 |
NR-ER | 0.776 | NR-ER-LBD | 0.559 |
NR-PPAR-gamma | 0.708 | SR-ARE | 0.934 |
SR-ATAD5 | 0.793 | SR-HSE | 0.702 |
SR-MMP | 0.974 | SR-p53 | 0.873 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.